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Abstract 
 
 
There is evidence to suggest that high altitude (HA) exposure leads to a fall in heart rate 
variability (HRV) that is linked to the development of acute mountain sickness (AMS). 
The effects of sex on changes in HRV at HA and its relationship to AMS are unknown. 
 
Methods 
 
 
HRV (5-minute single lead ECG) was measured in 63 healthy adults (41 men and 22 
women) aged 18-56 years at sea level (SL) and during a HA trek at 3619m, 4600m and 
5140m respectively. The main effects of altitude (SL, 3619, 4600 and 5140m) and sex 
(men vs women) and their potential interaction were assessed using a Factorial Repeated 
Measures ANOVA. Logistic regression analyses were performed to assess the ability of 
HRV to predict AMS. 
 
Results 
 
 
 
Men and women were of similar age (31.2 ±9.3 vs 31.7±7.5 years), ethnicity, body and 
mass index.   There was main effect for altitude on heart rate, SDNN (standard deviation 
[SD] of normal-to-normal [NN] intervals), RMSSD (Root mean square of successive 
differences), NN50 (number of pairs of successive NNs differing by >50 ms), pNN50 
(NN50 / total number of NNs), very low frequency (VLF), low frequency (LF), high 
frequency (HF) and total power (TP). The most consistent effect on post hoc analysis was 
reduction in these HRV measures between 3619 and 5140m at HA. Heart rate was 
significantly lower and SDNN, RMSSD, LF, HF and TP were higher in men compared 
with women at HA. There was no interaction between sex and altitude for any of the 
HRV indices measured. HRV was not predictive of AMS development. 
 
 
 
 
 
Conclusions
  
Increasing HA leads to a reduction in HRV. Significant differences between men and 
women emerge at HA. HRV was not predictive of AMS.
  
Introduction 
 
 
The assessment of heart rate variability (HRV) has rapidly evolved from what was 
predominantly a research tool to an increasingly appreciated clinical modality (1). Its 
most widespread translational use at present is in the assessment of psychological stress, 
physical fitness and the prevention of overtraining (1, 26). The improved portability and 
reduced cost of HRV-measurement equipment have also played a significant role in this 
regard.  HRV assessment relies on the detailed assessment of the variations in the time- 
intervals between consecutive heart beats which are subject to continuous autonomic 
control (26,28). From these data, the changes in the beat-beat intervals over time (time- 
domain analyses) can be more robustly quantified from as little as 1-5 minutes of 
recording (1,27,29). The beat-to-beat data can be further examined by frequency domain 
analysis whereby the generated sinusoidal waveforms of these intervals over time, are 
placed into various frequency components, allowing for a more in depth analysis of 
autonomic balance (26,28). 
 
An area of recent interest has been in the effects of high altitude (HA) on HRV 
(6-8, 20). HA exposure challenges several physiological systems that are heavily reliant 
on continuous autonomic control and are likely to influence HRV (7,8,21,22). Acute 
hypoxia and HA leads to marked sympathetic activation yet paradoxically there is also 
evidence of increased competing parasympathetic activity which contributes to the 
reduction in maximal heart rate in proportion to the altitude gained (7,8,19,21). 
Hypobaric hypoxia, cold, exercise, stress and fatigue, which are synonymous with HA 
exposure, are all known individually to influence HRV (8,16). 
 
There are data to suggest that acute hypoxia and HA exposure leads to a decline 
in HRV (8,20) with conflicting data on its potential link to HA-related symptoms and 
acute mountain sickness (AMS) (12,13,29). Published studies on HRV at HA have been 
derived from relatively small cohorts, with very little data on the effects of genuine
  
terrestrial, rather than simulated HA (6,12,13). Moreover, there has been an under- 
representation of women, in current datasets, despite their obvious physical and 
potentially important physiological differences compared to men. Resting heart rate tends 
to be higher in women than men, yet their stroke volumes and cardiac outputs are lower 
and these differences are sustained and even enhanced with hypoxia (5,14). Resting 
minute ventilation, which affects HRV, is relatively greater in women under both 
normoxia and hypoxia (23). Time-domain measures of HRV are typically higher in 
healthy men (<50 years) compared with age-matched women (5,14,24). However, the 
power spectral density (PSD) of HRV in females is usually characterized by less total 
power (TP), greater or similar high-frequency (HF) and lower low-frequency (LF) power 
and LF/HF ratios (14,27,28). 
 
There are some data to suggest that women may be also more vulnerable to both 
 
AMS development and worsening symptom severity compared with men (9,18,25). 
 
Given the possible sexual dimorphism in HRV and AMS incidence/severity coupled with 
the reported links between HRV and AMS an investigation of comparative HRV in men 
and women and its relationship to AMS development is warranted. 
 
In this study, we aimed to investigate, for the first time, the influence of sex on 
time and frequency-domain measures of HRV with increasing terrestrial HA and its 
potential link to AMS development. 
 
 
 
 
Methods 
 
 
Study design and participants 
 
 
Sixty-three healthy British Military servicemen aged >18years were included. They were 
all assessed at near SL (<200m) and again at three further altitudes during progressive 
HA ascent in the Dhaulagiri region of the Himalayas in March/April 2016. Health status
  
was confirmed following a detailed baseline questionnaire. For inclusion, all subjects 
needed to be low altitude dwellers and were required to be deemed medically fit for HA 
exposure by their medical practitioners. All participants were required to have 
successfully completed their mandatory military Personal Fitness Assessment 1.5 mile 
run in accordance with published standards (adjusted to age and sex) prior to inclusion. 
This run was undertaken in sports clothing on a flat surface. Subjects with a history of 
cardiac arrhythmias were excluded. The subjects were studied consecutively in groups of 
8-14 at sea level and at HA with a two-day stagger between successive groups.  All 
trekking groups followed an identical ascent and exercise recovery profile with similar 
morning wake times. Sea level (SL) baseline assessments were performed in the UK 
approximately six weeks prior to each departure. 
 
 
 
 
High Altitude Ascent and descent profile 
 
 
The subjects flew from the UK to Kathmandu (1400m) where they underwent two days 
of local acclimatisation (Days 1-3). Thereafter, they travelled by road over two days to 
1030m (Darbang). From there they commenced trekking on foot over the ensuing 11 
days to an altitude of 5140m (with an overpass of 5360m) before commencing their 
decent on foot to Marpha (2719m) and then by road back to Kathmandu. Research 
assessments were performed at SL and at static research camps at 3619m, 4600m and 
5140m during HA ascent. 
 
 
 
 
 
 
Physiological Assessments and Heart Rate Variability 
 
 
Oxygen saturations (SpO2) were measured using a Nonin Onyx (Nonin Medical Inc, 
Plymouth, Minnesota) pulse oximeter with sampling over approximately 15 seconds. 
HA-related symptoms were recorded using the Lake Louis Scoring (LLS) system. AMS
  
was defined as a LLS of >3 in the presence of headache (11,15).  HRV assessments were 
 
undertaken using dedicated battery-operated portable HRV devices which records a 
single lead ECG at a sampling rate of 250/second (CheckMyHeart Plus™ Daily Care 
Biomedical, Taiwan) as previously described (5). The first of the two surface ECG 
electrodes were placed at the right sternal edge at one finger breathe below the 
suprasternal notch and the second over the left 5th intercostal space at the mid clavicular 
line (i.e. cardiac apex).  Measurements were taken on fully rested subjects over a five- 
minute period in the early morning post-micturition and prior to breakfast or caffeine (6). 
All subjects were studied seated in a warm building at sea level and wearing warm 
clothing and in a tent at HA and were advised not to talk during HRV assessment. All 
stored recordings were exported via USB hook up for offline data analysis 
(CheckMyHeart Plus™ R30 V4, Daily Care Biomedical, Taiwan). 
 
The R waves of the stored ECG were used as the fucidal point to determine the beat to 
beat interval with full ECG disclosure. Non-normal-to-normal-(NN) intervals and ectopic 
beats were identified using customised software non-linear algorithms and were 
highlighted by colour coding within the HRV software to ease their identification. All 
ECG data was inspected in six second windows for further identification and manual 
editing of potential non NN intervals if necessary. All confirmed non NN intervals due to 
ectopy were excluded.   The average five-minute heart rate, and the SDNN, RMSSD, 
NN50 and pNN50 time domain measures, as previously described, were recorded 
(26,28). The SDNN refers to the standard deviation of the NN intervals from the acquired 
ECG. The RMSSD (Root mean square of successive differences) is the square root of the 
mean of the squares of the successive differences between adjacent NN intervals. The 
NN50 describes the number of pairs of successive NNs that differ by >50 ms and the 
pNN50 refers to the proportion of NN50 divided by total number of NN intervals. 
  
Frequency-domain analysis was performed using the non-detrend method of fast Fourier 
transformation (FFT) with full graphical display of the power spectral data. Key
  
frequency band data collected were the HF power (0.15-0.40 Hz), LF power (LF; 0.04- 
 
0.15 Hz), very low frequency power (VLF; 0.01-0.04 Hz), TP and the LF: HF ratio as 
previously defined (21,23). Normalized HRV values of LF (LFnu) and HF (HFnu) were 
calculated as a percentage of the total spectral power minus the VLF respectively (28). 
 
Ethics 
 
 
 
All participation was voluntary and all subjects underwent detailed written informed 
consent.  This study was approved by the Ministry of Defence Research and Medical 
Ethics Committee (MODREC) and was conducted according to the standards of the 
Declaration of Helsinki. 
 
 
 
 
 
Statistical analysis 
 
 
 
Data were analysed using GraphPad InStat version 3.05 and SPSS® statistics 
version 22 with all graphical figures presented using GraphPad Prism version 4.00 for 
Windows (GraphPad Software, San Diego, CA, USA). Sample size calculations were 
performed using a proprietary determined sample size calculator using (GraphPad 
StatMate version 2.00 for Windows). Data inspection and the Kolmogorov-Smirnov test 
was undertaken to assess normality of all continuous data, which were presented as mean 
± standard deviations and as the standard error of the mean (SEM) for figures. 
Categorical variables were compared using a Chi-Squared test. Comparison of unpaired 
data was performed using an independent t test and a Mann-Whitney test for parametric 
and non-parametric data respectively.  Correlations were performed using Pearson and 
Spearman rank correlation (±95% confidence interval, CI) for parametric and non- 
parametric data respectively.  A Factorial Repeated Measures ANOVA with Bonferroni 
correction (to minimise type I error) was performed to assess the main effect of sex (men 
vs women) over the four altitude time points (SL, 3619m, 4600m and 5140) and any
  
interaction of altitude x sex on HRV scores. Binary logistic regression analyses (enter) 
were undertaken to assess potential continuous HRV and other univariate predictors of 
AMS development (yes or no) and its coefficient (B). We also undertook an additional 
exploratory analysis of the categorical HRV measures of RMSSD <30ms, LF:HF >1.3 
and LFnu <20% that have been previously reported to be associated with AMS  (12,13) . 
Non-parametric data was log (Ln) transformed and normality confirmed for the ANOVA 
and logistic regression analyses. A two tailed P value <0.05 was considered statistically 
significant for all comparisons. 
 
 
 
 
Sample size calculations 
 
 
In a recent pilot study in Dhaulagiri, which included 12 subjects, we observed a non- 
significant but 11% (-7.9 ms) fall in the RMSSD time domain measure of HRV from 
baseline to 3600m, using identical HRV (CheckMyHeart Plus™) devices (6). Hence, by 
studying an even greater altitude of >5000m we calculated that a sample size of >18 
subjects in each group (men vs women) would have >80% power to detect a significant 
change in the RMSSD at HA at a significance level (alpha) of 0.05 (two-tailed). In 
another recent study Saleem et al documented that the SDNN was significantly higher in 
27 healthy men versus 18 healthy women (24). We estimated that a sample size of at 
 
least 18 women and >30 men studied across four differing altitudes would have sufficient 
power to detect a significant sex difference in HRV including SDNN. 
 
 
 
 
Results 
 
 
HRV data were available on 62 subjects at SL and at 3619 m and on 58 subjects at 
 
4600m and 5140m respectively. The men (31.2±9.3 years) and women (31.7±7.5 years) 
 
were well matched for age, ethnicity, smoking history and body mass index (table 1). As
  
expected, the men were on average taller and heavier with higher systolic blood pressures 
at baseline, with faster completion times for their mandatory annual 1.5 mile running 
fitness test (P<0.0001) (table 1). 
 
HA exposure led to a significant fall in SpO2 and an increase LLS among 
both men and women, compared to baseline with no effect for subject sex (table 2). Heart 
rate (five-minute average) increased at HA in both sexes, with women having 
consistently higher rates than men both at SL and at HA (table 2 and 4). 
 
 
 
There was a significant main effect for altitude on all time-domain measures of 
HRV. On post-hoc analysis this represented a significant reduction in time-domain 
measures of HRV most consistently between 3619m to 5140m (table 2 and 4; figure 1). 
There was a significant main effect for altitude on LF, HF and TP. This difference was 
again most marked on post-hoc analyses between 3619m and 5140m where significant 
reductions in LF, HF and TP were observed (table 3 and 4; Figures 2). 
 
Time domain measures of HRV were non-significantly higher in men at SL and 
significant differences emerged at HA, where all measures were notably higher in men 
(table 2 and 4; figure 1).  There was also a main effect for sex among the frequency 
domain measures of TP, LF and HF power which were all significantly higher in men at 
HA (table 3 and 4, figure 2). There were no interactions between sex (men vs women) x 
altitude (SL, 3619m, 4600m and 5140m) on any measures of HRV (table 4) or heart rate. 
 
SpO2 inversely correlated with LLS (r=-0.38; 95% CI -0.50 to -0.24; p<0.0001) 
and positively with RMSSD (r=0.16; p=0.02), SDNN (r=0.18; 0.05 to 0.30: p=0.007), 
VLF (r=0.17; 0.04 to 0.30; p=0.01), LF (r=0.16; 0.03 to 0.29; p=0.2) and TP (r=0.17; 
0.03 to 0.29; P=0.02). 
 
 
The prevalence of AMS increased at HA from 15.2% at 3619m to 27.3%  at 
 
4600m and 32.5% at 5140m (p=0.004). Reducing SpO2 (B -0.13; P<0.0001) and
  
increasing altitude (B 0.80; P <0.0001) and mean heart rate (B 0.03; P=0.04) were the 
only univariate predictors of AMS. None of the continuous measured HRV parameters or 
the categorical variable of subject sex (men vs women) were predictive of AMS. RMSSD 
<30ms, LF:HF >1.3 and LFnu <20% were not predictive of or associated with AMS. 
 
 
 
 
 
 
Discussion 
 
 
This is the largest study to assess the effects of HA on HRV, and to the author’s 
knowledge the first study to investigate the influence of sex on HRV at terrestrial HA. In 
this study HRV was influenced by HA. Minor sex-related differences in HRV that were 
observed at SL were sustained at genuine terrestrial HA. A link between HRV and 
symptoms of AMS were not found. 
 
We observed a significant fall in resting SpO2 and an increase in LLS with 
increasing HA. There was also a significant main effect for altitude on heart rate (which 
increased) and all the evaluated time-domain measured of HRV. The most consistent 
change was between 3619 and 5140m, and hence at higher altitude, where there was a 
significant fall in SDNN, RMSSD, NN50, PNN50, LF and HF power.  These findings 
are in keeping with published data that has shown a fall in time-domain measures of 
HRV at HA (12,13,29). These changes are in part explained by a number of factors 
linked to the HA environment. These include reducing sleep quality, extremes of cold 
and heat, physical exhaustion and increasing anxiety which are all known to adversely 
affect and reduce time domain measures of HRV (13,19,30). 
 
 
 
 
We also observed a significant main effect for sex on heart rate and time domain 
measures of HRV at HA, with men having consistently higher scores and greater 
variability. This is a novel finding. Whilst published data has shown a consistent trend to
  
higher time domain measures of HRV in young adult men versus women at SL (3,14,24). 
This is the first comparative study at HA. The trend to higher time domain HRV 
measures at SL became significant at HA. There was no interaction of altitude on sex on 
the time domain HRV parameters. This finding can be partly explained by the sex 
differences in heart rate which was consistently lower in the men. Heart rate is well 
known inversely correlate with all main time domain measures of HRV (28). 
 
We also observed a significant effect of altitude (SL, 3619m, 4600m and 5140m) 
on TP, VLF, LF and HF power. The most consistent finding, on post-hoc analyses was a 
reduction in these parameters at the highest altitude of 5140m vs sea level and 3619m. 
HA exposure was also associated with a significant main effect of sex with greater TP, 
LF and HF power among the men. Results from a very recently published meta-analysis 
of comparative HRV measures among men and women at SL, that included more than 
60,000 participants, demonstrated that when compared to that seen in women, PSD in 
men is generally characterised by lower HF power and greater LF, TP and LF/HF ratios 
(14). This is thought to reflect their higher resting sympatho-vagal tone (hence greater LF 
and LF/HF ratios) compared with women. Our LF data supports this previous data. 
However, contrary to the published data we found that HF power was actually higher 
with variable effects on LF/HF power among the men.  There are several potential factors 
that might explain these results. It is known that LF, HF power and their relative ratios 
(LF/HF) can be markedly influenced by a number of factors which include age, 
respiratory rate, recording length and heart rate (3,14,23,26,28). Whilst the ages were 
similar between the men and the women the greater heart rates in women would have led 
to the analysis of a higher number of beat-to-beat intervals, despite an identical recording 
period,  which could be an important  confounder. Secondly, whilst increasing heart rate 
and minute ventilation are HA are thought to relate to enhanced sympathetic activation 
there is also evidence of elevated parasympathetic neural activity (4,7,21,22). This 
increase in competing vagal activation at HA is thought to contribute to the reduction in
  
maximal heart rate at HA (7). LF power and the LF/HF ratio have been traditionally 
thought to represent sympathetic activation and net sympatho-vagal balance respectively 
with RMSSD and HF power reflecting parasympathetic nerve activity (28). However, 
there is evolving evidence to show that these arbitrary assumptions about the discrete 
autonomic effects these HRV measures, may be overly simplistic (2). 
 
Our identified sex-related dissimilarities in the time and frequency domain HRV 
measures at HA could also relate to differences in fitness levels. Indeed, the men in our 
study had higher time domain measures of HRV and lower 1.5 mile run times. Our 
findings could also relate dissimilarities in acclimatisation in men vs women. 
Acclimatisation encompasses the cumulative effects of multiple factors such as 
hydration, ventilation and enuresis that are known to influence autonomic balance and 
HRV (10). HRV, and in particular frequency domain analysis can be significantly 
affected by breathing pattern and ventilation, which are markedly affected HA where 
hypoxia driven hyperventilation predominates (14,17,18). In our study paced breathing 
during HRV assessments were not performed, but the participants were encouraged to 
relax and breathe normally.  The majority of published studies on HRV at HA have 
utilised spontaneous non-paced breathing, hence were keen to utilise a comparative 
methodology (7,9,10,24).  Our participants were assessed at far higher altitudes and 
under greater hypoxia than most of the previous HA HRV studies to date, hence the 
potential challenge to paced breathing was likely to have been greater. We anticipated 
that at 4600 and 5140m controlled breathing under significant hypoxia and a high 
ventilatory drive might paradoxically increase subject anxiety and perceived 
breathlessness.  By enforcing a similar paced breathing protocol in both men and women 
we risked neutralising genuine sex-related differences in HRV related to well-reported 
dissimilarities in ventilation between men and women at HA (2,19). Unfortunately, we 
did not measure comparative respiratory rate and ventilation among the men vs women.
  
This is an obvious limitation as sex-related differences in their spontaneous breathing it 
could have provided further insight into the observed differences in HRV identified. 
 
We did not observe a link between AMS and HRV in this current study. There is 
limited evidence linking changes in HRV to AMS, raising the prospect of using HRV as 
a non-invasive predictor of AMS development (9,10). In a previous study Karinen et al 
investigated 36 different healthy climbers ascending from 2400 m to 6300 m altitudes 
during five differing expeditions and noted that a lower RMSSD and HF at 2400m was a 
marker of AMS at 3000 to 4300m (10). However, contrary to our study, the speed of 
ascent varied between their five studied groups. Furthermore, they measured HRV over 
two rather than five minutes. In another study, of similar size (n=32), Hang et al noted 
that a HF% <20% (nu) or LF/HF ratio >1.3 at lower altitudes was predictive of AMS at 
3400m (9). These HRV parameters failed to be either associated or predict AMS in or 
study. Willie et al in a prolonged normobaric hypoxia study and our group in another 
recent study (ithlete RMSSD-derived HRV score), failed to identify a clear link between 
AMS and HRV supporting our data (16, 23). 
 
The potential reasons for the contradictory findings in HRV to predict AMS may 
relate to differences in study design, HA environment, ascent/hypoxic profile, HRV 
recording time as well as the actual HRV parameters measures.  Even the definitions of 
AMS that were used differed between these studies. For example, Karinen et al defined 
AMS as a LLS of >3 in their study whereas in the study by Willie they a LLS ≥4 was 
 
used to define AMS (10,24). In our study we used the Lake Louise Consensus definition 
 
(1992) for AMS, which is refers to LLS score of >3 in the presence of headache (4,8,12). 
 
It is well known that AMS is a highly complex and heterogeneous condition. Its 
causative mechanisms include changes in cerebral arterial blood flow and increased 
vascular permeability within the blood brain barrier, both of which may be influenced by 
  
local autonomic control (18). Whilst HRV reflects overall cardiac autonomic control it is 
relatively non-specific and is not indicative of local autonomic balance (2,18).
  
This study has several additional imitations that should be mentioned. The 
 
subjects were studied in consecutive groups of 8-14 two days apart and not all together in 
one batch. This was because of the large sample size for this type of remote field study 
and the need to undertake at HRV in the early morning pre-breakfast and caffeine.  We 
measured five minute HRV which may be more vulnerable to short-term sex and 
situational bias than that obtained from longer recordings (22). However, five minute 
HRV measurement is well-validated and endorsed by the current HRV Task Force 
Guidelines and is more potentially applicable to clinical practice than that of longer 
recordings (22). We included a larger proportion of men than women and cannot exclude 
the possibility of sample bias, despite their similarities in age, ethnicity, smoking history 
and body mass index. 
 
In conclusion our findings indicate that increasing HA was associated with a 
reduction in HRV which was most notable at 4600m and above.  There were significant 
sex related differences in HRV between men and women which were sustained at HA. 
There was no interaction between sex and altitude on any of the HRV parameters 
measured. These sex-related differences may reflect dissimilarities in their autonomic 
balance and acclimatisation to HA. HRV was not predictive of AMS. 
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Legends for Figures 
 
 
Figure 1 Comparative Changes in the RMSSD (mean ± SEM) among men and women at 
sea level and increasing high altitude. Post-test differences on repeated measures ANOVA: 
* versus sea level, ‡ 3619 vs 5140m, †3619 vs 4600m. 
 
 
 
 
 
Figure 2 Comparative Changes in Low frequency (LnLF) Power (mean ± SEM) among 
men and women at sea level and increasing high altitude. Post-test differences on repeated 
measures ANOVA: * versus sea level, ‡ 3619 vs 5140m. 
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Table 1 
 
 
 
 
 
 
Table 1: Baseline Demographics 
 
 
Demographic 
 
Overall 
 
Men 
 
Women 
 
P value* 
 
Number (%) 
 
63 (100%) 
 
41 (65%) 
 
22 (35%) 
 
 
Age, years (range) 
 
31.41 ± 8.7 (18-56) 
 
31.2 ± 9.3 
 
31.7 ± 7.5 
 
0.83 
 
Height (cm) 
 
173.4 ± 9.7 
 
177.1±9.3 
 
166.5±5.8 
 
<0.0001 
 
Weight (kg) 
 
72.5 ± 13.0 
 
77.4±12.1 
 
63.2 ± 9.3 
 
<0.0001 
 
Body mass index, kg/m2 
 
24.0 ± 2.8 
 
24.2 ± 3.0 
 
23.5± 2.6 
 
0.36 
 
Systolic blood pressure 
 
(mmHg) 
 
132.1 ± 15.6 
 
136.9 ± 15.1 
 
123.7 ± 12.7 
 
<0.0001 
 
Diastolic blood pressure 
 
(mmHg) 
 
80.5 ± 14.6 
 
80.8 ± 12.4 
 
78.7 ± 10.7 
 
0.53 
 
Basic fitness test time 
 
(minutes) 
 
9.9  ± 1.3 
 
9.5 ± 1.1 
 
10.8 ± 1.2 
 
<0.0001 
 
Hormonal contraception 
 
(pill / implant) 
 
5 (7.9%) 
 
0 
 
5 (22.7%) 
 
<0.0001 
 
Ethnicity, % 
 
- Caucasian 
 
- Non Caucasian 
 
 
 
56 (88.9%) 
 
7 (11.1%) 
 
 
 
35 (85.4%) 
 
6 (14.6%) 
 
 
 
21 (95.5%) 
 
1 (5.5%) 
 
 
 
 
 
 
0.40 
 
Smoking status (%) 
 
- Never 
 
- Current 
 
- Ex 
 
 
 
51 (81.0%) 
 
4 (6.3%) 
 
8 (12.7%) 
 
 
 
33 (80.4%) 
 
4 (9.8%) 
 
4 (9.8%) 
 
 
 
18 (81.8%) 
 
0 (0%) 
 
4 (18.2%) 
 
 
 
 
 
 
 
 
0.23 
 
*p value refers to results of comparison of men vs women only 
  
Table 2 
 
 
 
 
 
 
Table 2 Changes in SpO2 and time domain measures of Heart rate Variability at sea level to 
increasing high altitude 
 
 
 
 Sea level 3619m 4600m 5140m Post-test Paired 
 
differences for 
effects of altitude 
SpO2 (%) 
 
-Men 
 
-Women 
 
 
97.7 ±1.3 
 
97.9 ± 1.3 
 
 
93.1 ± 3.2 
 
90.9 ± 4.5 
 
 
83.5 ± 6.0 
 
80.4 ± 8.5 
 
 
81.3 ± 5.3 
 
78.6 ± 5.4 
 
 
abcef 
Lake Louis Scores 
 
-Men 
 
-Women 
 
 
0.4 ± 0.6 
 
0.5 ± 0.9 
 
 
1.0 ± 2.1 
 
1.5 ± 2.4 
 
 
1.9 ±2.2 
 
2.3 ± 1.2 
 
 
1.5 ± 1.5 
 
1.3 ±1.4 
 
 
abc 
Mean heart rate/minute 
 
-Men 
 
-Women 
 
 
57.6 ± 9.0 
 
60.8 ± 9.7 
 
 
63.6 ± 12.0 
 
69.5 ± 9.4 
 
 
72.7 ± 15.2 
 
79.5 ± 12.8 
 
 
74.5 ± 15.7 
 
81.1 ± 11.8 
 
 
abcde 
SDNN (ms) 
 
-Men 
 
-Women 
 
 
78.1 ± 25.2 
 
76.0 ± 28.3 
 
 
94.8 ± 55.9 
 
74.6 ± 29.1 
 
 
85.0 ± 451.7 
 
52.5 ± 20.8 
 
 
72.1 ± 49.2 
 
51.4 ± 28.0 
 
 
abcde 
RMSDD (ms) 
 
-Men 
 
-Women 
 
 
67.0 ± 31.6 
 
59.6 ± 32.2 
 
 
93.2 ± 72.9 
 
60.8 ± 30.2 
 
 
76.2 ± 56.4 
 
37.3 ± 19.5 
 
 
62.2 ± 54.6 
 
41.5 ± 32.6 
 
 
cde 
NN50 
 
-Men 
 
-Women 
 
 
104.8 ± 38.6 
 
96.3 ± 54.6 
 
 
113.0 ± 76.0 
 
104.8 ±59.1 
 
 
105.5 ± 75.2 
 
54.4 ± 51.4 
 
 
81.9 ± 64.0 
 
60.0 ± 65.3 
 
 
ce 
pNN50 (%) 
 
-Men 
 
-Women 
 
 
37.8 ± 19.8 
 
32.8 ± 19.8 
 
 
39.6 ± 27.8 
 
32.2 ± 18.8 
 
 
34.1 ± 25.6 
 
14.7 ± 14.3 
 
 
26.5 ±22.2 
 
16.4 ± 18.8 
 
 
cde 
Results of post hoc paired differences with time (altitude) for both men and women: a, sea level vs 3619m; b 
 
sea level vs 4600m; c sea level vs 5140m; d, 3619m vs 4600m; e, 3619 vs 5140m; f 4600m vs 5140m 
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Table 3 Changes Frequency domain measures of Heart rate Variability at sea level to 
increasing high altitude 
 
 Sea level 3619m 4600m 5140m Post-test Paired 
 
differences for 
effects of altitude 
Total power (ms2) 
 
-Men 
 
-Women 
 
 
7.87 ± 0.7 
 
7.75 ± 0.7 
 
 
7.95 ± 1.4 
 
7.73 ± 0.8 
 
 
7.86 ± 1.6 
 
7.05 ± 0.7 
 
 
7.34 ± 1.5 
 
7.0 ± 1.0 
 
 
cef 
VLF (ms2) 
 
-Men 
 
-Women 
 
 
6.06 ± 0.7 
 
6.16 ± 0.8 
 
 
6.11 ± 1.2 
 
5.92 ± 0.9 
 
 
6.00 ± 1.3 
 
5.44 ± 0.7 
 
 
5.62 ± 1.3 
 
5.28 ± 1.1 
 
 
ce 
LnLF (ms2) 
 
-Men 
 
-Women 
 
 
6.80 ± 0.8 
 
6.44 ± 0.7 
 
 
6.61 ± 1.4 
 
6.67 ± 1.0 
 
 
6.62 ± 1.7 
 
5.89 ± 0.9 
 
 
6.19 ± 1.4 
 
5.76 ± 1.0 
 
 
ce 
LnHF (ms2) 
 
-Men 
 
-Women 
 
 
6.55 ± 0.8 
 
6.23 ± 1.0 
 
 
6.87 ± 1.7 
 
6.36 ± 0.9 
 
 
6.50 ± 2.1 
 
5.47 ± 1.0 
 
 
6.09 ± 1.8 
 
5.43 ± 1.3 
 
 
e 
LF%, nu 
 
-Men 
 
-Women 
 
 
55.4 ± 15.9 
 
44.5 ± 18.8 
 
 
44.7 ± 18.0 
 
56.8 ± 15.6 
 
 
52.7 ± 17.9 
 
58.8 ± 16.4 
 
 
52.0 ± 18.8 
 
56.8 ± 20.6 
 
 
NS 
HF%, nu 
 
-Men 
 
-Women 
 
 
44.6 ± 15.9 
 
45.7 ± 18.4 
 
 
55.4 ± 18.0 
 
43.2 ± 15.6 
 
 
47.3 ± 17.6 
 
41.2 ± 16.4 
 
 
48.0 ± 18.8 
 
43.2 ± 20.6 
 
 
NS 
LF / HF 
 
-Men 
 
-Women 
 
 
1.7 ± 1.3 
 
1.4 ± 1.1 
 
 
1.0 ± 0.80 
 
1.6 ± 1.0 
 
 
1.6 ± 1.5 
 
2.1 ± 1.8 
 
 
1.6 ± 1.5 
 
2.2 ± 2.2 
 
 
NS 
NS, Non-significant; Results of post hoc paired differences with time for men and women 
combined: a, sea level vs 3619m; b sea level vs 4600m; c sea level vs 5140m; d, 3619m vs 
4600m; e, 3619 vs 5140m; f 4600m vs 5140m 
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Table 4 Results of Two-way Repeated Measures ANOVA comparing the main effects of 
altitude (SL, 3619m, 4600m and 5140m) and sex (men vs women) on measures of heart rate 
variability 
 
 
 
Time (altitude)                         Sex                       Interaction 
 
  
F 
  
P value 
  
F 
  
P value 
  
F 
  
P Value 
 
SpO2 
  
165.20 
  
<0.001abcef 
  
0.49 
  
0.48 
  
0.21 
  
0.89 
 
Lake Louis Scores 
 
 
4.30 
 
 
0.008abc 
 
 
0.37 
 
 
0.55 
 
 
0.63 
 
 
0.60 
 
Mean heart rate 
 
 
47.3 
 
 
<0.001abcde 
 
 
4.10 
 
 
0.04 
 
 
0.43 
 
 
0.73 
 
SDNN 
 
 
40.6 
 
 
<0.001abcde 
 
 
4.00 
 
 
0.04 
 
 
1.14 
 
 
0.26 
 
RMSDD 
 
 
8.10 
 
 
<0.001cde 
 
 
4.40 
 
 
0.04 
 
 
0.94 
 
 
0.43 
 
NN50 
 
 
8.20 
 
 
<0.001ce 
 
 
3.20 
 
 
0.08 
 
 
0.82 
 
 
0.47 
 
PNN50 
 
 
10.7 
 
 
<0.001cde 
 
 
3.50 
 
 
0.06 
 
 
0.94 
 
 
0.41 
 
SD1 / SD2 
 
 
1.89 
 
 
0.13 
 
 
4.90 
 
 
0.03 
 
 
0.34 
 
 
0.80 
 
Total power 
 
 
8.40 
 
 
<0.001cef 
 
 
4.20 
 
 
0.04 
 
 
1.87 
 
 
0.14 
 
VLF 
 
 
7.10 
 
 
<0.001ce 
 
 
2.00 
 
 
0.17 
 
 
1.76 
 
 
0.16 
 
LF 
 
 
7.10 
 
 
<0.001ce 
 
 
3.80 
 
 
0.048 
 
 
1.70 
 
 
0.17 
 
HF 
 
 
5.80 
 
 
0.001e 
 
 
5.80 
 
 
0.02 
 
 
1.26 
 
 
0.29 
 
LFnu 
 
 
0.39 
 
 
0.76 
 
 
3.10 
 
 
0.09 
 
 
1.70 
 
 
0.17 
 
HFnu 
 
 
0.39 
 
 
0.76 
 
 
3.10 
 
 
0.09 
 
 
1.70 
 
 
0.17 
 
LF / HF 
 
 
0.50 
 
 
0.70 
 
 
1.60 
 
 
0.20 
 
 
3.50 
 
 
0.07 
 
SpO2, oxygen saturations;  Results of post hoc paired differences with time (altitude) a, sea 
level vs 3619m; b sea level vs  4600m; c sea level vs 5140m; d, 3619m vs 4600m; e, 3619 vs 
5140m; f 4600m vs 5140m
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